Literature DB >> 24500702

Intra-arterial infusion and chemo-embolization for melanoma liver metastases.

Suhrid Lodh1, Richard Maher, Alexander Guminski.   

Abstract

This article will review the rationale for hepatic arterial administration of agents to treat melanoma liver metastases, the techniques and practical considerations pertinent to hepatic arterial therapy, the variety of agents that have been used and the reported outcomes. Recent and emerging developments will be highlighted and the potential role of liver-directed therapies in the context of molecular advances and improved systemic therapy will be discussed.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  hepatic-arterial-therapy; liver; melanoma; metastases

Mesh:

Year:  2014        PMID: 24500702     DOI: 10.1002/jso.23551

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.

Authors:  Brian A Boone; Samantha Perkins; Rupal Bandi; Ernesto Santos; Kevin McCluskey; David L Bartlett; James F Pingpank
Journal:  J Surg Oncol       Date:  2018-04       Impact factor: 3.454

2.  Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.

Authors:  Jesus Vera-Aguilera; Agop Y Bedikian; Roland L Bassett; Wen-Jen Hwu; Kevin B Kim; Yong Qin; Suzanne Cain; Edwina W Washington; Michael A Davies; Sunil M Patel; Jade Homsi; Nicholas E Papadopoulos; Patrick Hwu; Sapna P Patel
Journal:  Am J Clin Oncol       Date:  2018-11       Impact factor: 2.339

3.  Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.

Authors:  Ioannis Karydis; Alexandra Gangi; Matthew J Wheater; Junsung Choi; Iain Wilson; Kerry Thomas; Neil Pearce; Arjun Takhar; Sanjay Gupta; Danielle Hardman; Sean Sileno; Brian Stedman; Jonathan S Zager; Christian Ottensmeier
Journal:  J Surg Oncol       Date:  2017-12-28       Impact factor: 3.454

4.  Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study.

Authors:  Lujun Shen; Han Qi; Shuanggang Chen; Fei Cao; Lin Xie; Ying Wu; Weimei Ma; Ze Song; Hui Yuan; Tao Zhang; Dandan Li; Xizhi Wen; Qifeng Chen; Wang Li; Xiaoshi Zhang; Weijun Fan
Journal:  Cancer Immunol Immunother       Date:  2020-04-24       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.